THE JOURNEY PRO STUDY: FEASIBILITY AND USER ACCEPTANCE OF A SMARTPHONE APP TO ASSESS THE BURDEN OF ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), β-THALASSEMIA (BT), AND MYELOFIBROSIS (MF). Pariseau J, Hu XH, Mahmoud D, Glasmacher A, Hudson M, Jessent-Ciaravino V, Gwaltney C, Kellen M, Omberg L, Snyder P, Mangravite L, Laadem A. HemaSphere. ;3:1011. 2019 Jun. doi: 10.1097/01.HS9.0000567516.23371.57.